Find clinical trials for Lung Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near London, England, GBR:
Probe Breath Biopsy Test to differentiate between individuals with lung cancer and relevant contrast groups.The contrast groups wil...
Phase 2
London, United Kingdom and 8 other locations
stereotactic body radiotherapy (SBRT) for early stage non-small cell lung cancer.SBRT will be delivered in either 3 or 5 fractions ...
Phase 1, Phase 2
Sutton, United Kingdom
a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non-small-cell lung...
Phase 2
London, United Kingdom and 48 other locations
The trial consists of a series of parallel multi-centre single arm phase II trial arms, each testing an experimental targeted drug in a population st...
Phase 2
London, United Kingdom and 24 other locations
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
London, United Kingdom and 209 other locations
This is a Phase II, multi-site, open-label, parallel group study in participants with untreated extended-stage small-cell lung cancer...
Phase 2
London, United Kingdom and 41 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
London, United Kingdom and 52 other locations
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
London, United Kingdom and 123 other locations
This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...
Phase 3
London, Other, United Kingdom and 140 other locations
KRAS G12C inhibitors (sotorasib or adagrasib) in participants with KRAS G12C-positive (KRAS G12C +) advanced or metastatic non-small cell lung...
Phase 3
London, United Kingdom and 61 other locations
Clinical trials
Research sites
Resources
Legal